Aurora Cannabis upgraded to overweight on prospects for European business


Aurora Cannabis ACB, +7.75% ACB, +8.65% rallied 6% in premarket trades on Friday after Cantor Fitzgerald analyst Pablo Zuanic upgraded the Canadian cannabis company to overweight from neutral and raised his 12-month price target on the stock to C$4.05 ($3.12) from C$3.90. Zuanic said Aurora Cannabis could benefit from growth in the legal cannabis market in Europe, as one of only two North American companies with a license to grow cannabis in Germany, along with Tilray Brands Inc. TLRY, +0.84%. “With questions as to whether imports will be allowed in the future German rec market and likely a limited number of new domestic production licenses issued to supply that future rec market, we believe both Tilray and Aurora should be well positioned,” Zuanic said. He described Aurora as an “attractively-valued pure cannabis global play.”

This article was originally published by Read the original article here.

Previous article: Clarence Thomas says Supreme Court should reconsider rulings on gay marriage, contraception
Next articleKey Words: Medical groups warn of ‘negative mental-health outcomes’ after Supreme Court overturns Roe v. Wade


Please enter your comment!
Please enter your name here